Effects of 8-alkylberberine derivatives on cholesterol metabolism and low-density lipoprotein receptor

Shi Qing,Ye Xiaoli

DOI: https://doi.org/10.3969/j.issn.2095-2783.2012.12.011

2012-01-01

Abstract:The effects of 8-alkyl-berberine derivatives(8-BBR-Cn) on low-density lipoprotein receptor(LDLR) expression and antihyperlipidemic levels have been studied.The Western blot was used to analyze the variation of LDLR protein expression in HepG2 and liver tissues,and the levels of TC,TG,LDL-C and HDL-C were also measured.The results showed that in HepG2 cells,the expression of LDLR increased with the elongation of the aliphatic chain.Among all compounds synthesized and BBR,8-cetyl-berberine(8-BBR-C16) was shown to obviously enhance the expression of LDLR in HepG2 cells.Further results in animal experiments indicated that 8-BBR-Cntreatment changed markedly the levels of TC,TG,LDL-c and HDL-c in serum and LDLR in hamster livers,compared with the hyperlipidemic control group;statistical analysis revealed that TC,TG,LDL-c and HDL-c decreased significantly(p<0.01) by 31.9%,14.4%,21.5% and 22.8%,respectively,with 8-BBR-C16 treatment.Moreover,LDLR protein expression was significantly increased by about 3.3-fold in HepG2 cells and 2.89-fold in livers(p<0.01).All these results demonstrated that 8-BBR-Cnwith a moderate length of aliphatic chain can improve the cholesterol level better than BBR;8-BBR-C16 is especially a potential compound to lower cholesterol level by adjusting the LDLR expression.